Revolutionary Science Brings Back Olympic Hopes
01 Março 2012 - 10:00AM
Marketwired
Therapy Cells, Inc. (OTCBB: TCEL) announces the following.
Two years ago, "Angeli," a horse from Southern California, was
facing retirement or at worst euthanasia as his career as a
contender at the 2012 Olympic Games was in tatters. Just the
previous weekend, he and his International Rider and Trainer,
Harley Brown of Australia, had been unable to compete in a major
Californian Show, as the previously Grand Prix level show jumper
could not jump even the lowest of jumps.
Then a phone call was made to an internationally acclaimed
Veterinarian and Scientist who travels around the world as an
International Consultant from New Zealand.
Three days later, Dr Patrick Casey arrived with his ultrasound
machine and after examining "Angeli," he proceeded to give Harley
the heartbreaking news. "Sorry mate but he's torn his hind tendon
badly, sort of shredded it!' explained Dr Casey.
Tendon injuries can be career ending for horses: only 5 to 15
percent of those with damaged tendons will ever make it back to
competition. Dr Casey, whose reputation had preceded him, then
explained a revolutionary new tendon treatment that had already
been shown to get 85% of the torn tendon horses back to full
competition. This treatment takes approximately 100 tendon cells
from the injured horse without causing any harm to the patient.
Using a patented procedure, 20 to 40 million tendon cells are then
grown in an incubator and transplanted back to the site of injury.
Harley Brown and "Angeli's" owner Mark Harryman knew that unless
they had a go, all hope was lost and they may have to bury their
pride and joy! They decided to go for the revolutionary
treatment.
In 2011, Dr Casey set up a public company in the USA -- Therapy
Cells, Inc. (TCEL on the OTC Market).
This exciting Bio Tech/Med tech Company holds the exclusive
technology that allows adult cells from a specific tissue (e.g.
Achilles tendon) to grow again from an individual to enact repair
and regeneration of that tissue, effectively by-passing the need
for Stem Cell Treatment.
Therapy Cells, Inc. has developed a novel and highly efficient
method of growing tendons and articular cartilage for auto
transplantation into injured horses or people. Of real interest to
veterinarians worldwide is the clinical success in horses.
Sixty-six horses have been treated with Therapy cells to date. The
data accumulated from horses will ultimately have direct
application to FDA approval for human use.
Therapy Cells revolutionary science dispenses with the
traditional notion that cells cannot divide once they are fully
mature. Dr Casey has shown that adult cells, given the right
environment, can be induced to divide in the laboratory. These
newly grown cells can then be put back into damaged tissue in the
body, to enact tissue and organ healing.
This revolutionary science dispenses with the traditional notion
that cells cannot divide once they are fully mature. Dr Casey has
shown that adult cells, given the right environment, can in fact
divide and be grown in the laboratory. These new cells can then be
used for transplantation back to damaged tissue in the body, to
enact tissue and organ healing.
The fairy tale continues for "Angeli" as not only was his
shredded tendon healed, he is on the squad and has a chance to be
selected to jump at the London Olympics for Australia with Harley
Brown. "We just could not have ever imagined how well this science
works," said Brown. "I have never heard of a horse coming back from
this injury, let alone being competitive at the highest level, it's
just like a dream."
In late March, the team (Casey, Brown and Harryman) will be
reunited in Wellington, Florida, where "Angeli's" American
preparation will end and he will fly to Europe for more pre Olympic
trialing. It is fair to say that Dr Casey "wouldn't miss it for the
world and considering where I come from wouldn't mind a cold one to
celebrate."
"With a growing level of trial success in horses, Therapy Cells'
target is to gain FDA approval, and in short order has direct
application for human tendon repair," Dr Casey says. "An initial
valuation of $30 million USD for our science and technology has
been appraised. FDA approval for clinical use of this technology in
the Human, will likely increase this factor by at least 10
times."
For further information Dr Casey can be contacted at
info@therapycells.com, www.therapycells.com, and Facebook: Therapy
Cells
*Dr Casey is a Veterinary graduate from Massey
University (BVSc, 1988, at the age of 21), and graduate from the
University of California in 1992 with a Doctor of Philosophy (PhD,
Comparative Pathology). During his time in the United States he
also completed an Equine Surgical Internship at Hagyard-Davidson
and McGee, Lexington, Kentucky, followed by a three year residency
program in Equine Reproduction, with a minor in Equine Medicine at
UC Davis. In 1992, 1993, and 1994 he received a post-doctoral
fellowship from the Equine Research Laboratory at the University of
California, which allowed him to set up with the late, world
renowned, Professor Liggins at the University of Auckland, New
Zealand.
CONTACT Therapy Cells, Inc. Dr Patrick Casey
info@therapycells.com www.therapycells.com
XTRA Bitcoin (PK) (USOTC:CBTC)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
XTRA Bitcoin (PK) (USOTC:CBTC)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024